SynthesisFrontiers in public health2024
Social determinants of health and upper gastrointestinal cancer outcomes in the United States: a systematic review.
Synthesis in Frontiers in public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Impact of Socioeconomic Status on Early Gastric Cancer Outcomes and Treatment Disparity: a SEER analysis.Journal of gastrointestinal cancer · 2026Article
- Social Determinants of Health Coding Among Hospital Visits Made by Adults With Cancer.JCO oncology practice · 2026Article
- Gastrointestinal Cancer: Outcomes and Therapeutic Management.Journal of clinical medicine · 2025Article
- Common Risk Factors in Gastrointestinal Cancers: A Narrative Review.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Social determinants of health (SDOH) are the conditions in which individuals are born, grow, work, live, and age. Methods: We examined the literature on the association between SDOH and survival of patients with gastrointestinal (GI) cancer [esophageal, duodenal and gastric cancer (GC)] in the United States from 2001 to 2022. Results: From 38,654 studies across COCHRANE, EMBASE, SCOPUS, WEB OF SCIENCE, and PubMed, we identified 14 relevant studies focusing on GI cancer using the PRISMA flowchart. Eight of the 12 GC studies specifically focused on gastric adenocarcinoma (GAC), the most common histologic subtype. Uninsured patients had a significantly worse overall survival probability. For patients with GI cancer, the highest income level (i.e., in the highest quartile) was associated with improved survival. Being unmarried had a negative impact on overall survival. Overall, people with insurance, higher incomes, and who were married had better overall survival rates. Discussion: Our findings suggest a clear association between SDOH and survival for patients with GI cancers. However, there is great variability in the factors studied and how these are measured and reported. A better understanding of SDOH is needed to design strategies with an aim to improve patient outcomes. Systematic review registration: https://www.crd.york.ac.uk/prospero/, PROSPERO (CRD42022346854).
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.